Here are four new drug shortages and discontinuations, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists.
- Gemcitabine hydrochloride injection: Hospira has discontinued manufacturing of its 200 milligram/5.26 milliliter, 1 gram/26.3 milliliter and 2 gram/52.6 milliliter NovaPlus single-dose glass vials of gemcitabine hydrochloride injection, an oncology medication used to treat various cancers.
- Ibandronate sodium injection: Apotex and Eugia US have reported a shortage of Ibandronate sodium 1 milligram/milliliter and 3 milliliter prefilled syringes, an intravenous drug used to treat osteoporosis. No reason was provided and supply is intermittent with Apotex estimating resupply by mid-November.
- Metyrosine capsules (Demser): Bausch Health has reported a shortage of its 250 milligram Demser oral capsules, used to manage pheochromocytoma. No reason was provided and the company cannot estimate a resupply date. Alternative 250 milligram capsules from Amneal pharmaceuticals are available, and capsules from Dr. Reddy’s Laboratories are forthcoming.
- Mometasone furoate and formoterol fumarate inhalation aerosol (Dulera): Organon has reported a shortage of its 100 microgram/5 microgram and 13 gram, and 100 microgram/5 microgram and 8.8 gram metered-dose inhalers of Dulera, used to manage asthma and obstructive pulmonary disease. No reason for the shortage was provided. Limited supply of alternative strengths including 50 microgram/5 microgram and 200 microgram/5 microgram is available, with the 100 microgram/5 microgram 8.8 gram inhalers expected to be resupplied by mid-October and 13 gram inhalers by mid-September.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
